What is Seaport Res Ptn’s Forecast for Ashland Q1 Earnings?

Ashland Inc. (NYSE:ASH) – Analysts at Seaport Res Ptn reduced their Q1 2026 earnings estimates for shares of Ashland in a research note issued to investors on Wednesday, November 5th. Seaport Res Ptn analyst M. Harrison now forecasts that the basic materials company will earn $0.24 per share for the quarter, down from their prior estimate of $0.26. The consensus estimate for Ashland’s current full-year earnings is $4.27 per share. Seaport Res Ptn also issued estimates for Ashland’s Q2 2026 earnings at $1.11 EPS, Q3 2026 earnings at $1.23 EPS, Q4 2026 earnings at $1.33 EPS, FY2026 earnings at $3.92 EPS, Q1 2027 earnings at $0.48 EPS, Q2 2027 earnings at $1.37 EPS, Q3 2027 earnings at $1.44 EPS and Q4 2027 earnings at $1.54 EPS.

A number of other analysts also recently weighed in on ASH. UBS Group cut their price target on shares of Ashland from $73.00 to $64.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Morgan Stanley started coverage on shares of Ashland in a research report on Monday, September 8th. They set an “equal weight” rating and a $60.00 target price on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Ashland in a research report on Wednesday, October 8th. BMO Capital Markets lifted their price objective on Ashland from $60.00 to $61.00 and gave the stock a “market perform” rating in a research report on Tuesday, September 2nd. Finally, Zacks Research lowered shares of Ashland from a “hold” rating to a “strong sell” rating in a research note on Friday, October 24th. Four analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $60.43.

Ashland Stock Performance

Shares of ASH stock traded down $0.34 on Friday, hitting $49.95. The company’s stock had a trading volume of 44,620 shares, compared to its average volume of 649,565. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.33 and a current ratio of 2.68. Ashland has a fifty-two week low of $45.21 and a fifty-two week high of $81.86. The stock’s 50 day moving average is $50.43 and its 200-day moving average is $51.29. The company has a market capitalization of $2.28 billion, a PE ratio of -2.66, a PEG ratio of 11.41 and a beta of 0.49.

Ashland (NYSE:ASH) last posted its quarterly earnings results on Thursday, June 9th. The basic materials company reported $0.56 earnings per share for the quarter. The firm had revenue of $509.00 million for the quarter. Ashland had a positive return on equity of 6.82% and a negative net margin of 46.01%. Ashland has set its FY 2022 guidance at EPS.

Institutional Trading of Ashland

Hedge funds and other institutional investors have recently made changes to their positions in the stock. State of New Jersey Common Pension Fund D increased its position in shares of Ashland by 4.9% during the third quarter. State of New Jersey Common Pension Fund D now owns 39,470 shares of the basic materials company’s stock valued at $1,891,000 after buying an additional 1,831 shares during the period. Krilogy Financial LLC purchased a new position in shares of Ashland during the 3rd quarter valued at about $517,000. Callan Family Office LLC bought a new position in shares of Ashland during the 3rd quarter valued at $202,000. State of Wyoming purchased a new position in shares of Ashland in the third quarter worth about $57,000. Finally, Oak Harbor Wealth Partners LLC boosted its stake in shares of Ashland by 50.6% during the third quarter. Oak Harbor Wealth Partners LLC now owns 15,569 shares of the basic materials company’s stock valued at $746,000 after purchasing an additional 5,229 shares during the period. 93.95% of the stock is currently owned by institutional investors.

Ashland Company Profile

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.